Fibroma medical therapy
overview
Medical therapy depends on the type of fibroma.
Medical therapy
Uterine fibroma
At present, there are no definitive agents for long-term medical treatment of uterine fibroma approved by Food and Drug Administration (FDA). But however, there are some agents that can be used in the management of this common benign tumor.[1][2][3][4][5][6]
Gonadotropin-Releasing Hormone Analogues
Gonadotropin-releasing hormone analogues can effectively reduce uterine leiomyoma volume, menorrhagia(heavy menstrual bleeding), and also stabilize hemoglobin levels by inducing an iatrogenic reversible menopause. Leuprolide, Buserelin, Nafarelin, Deslorelin, Histrelin, Goserelin, Tryptorelin
- ↑ Sabry, Mohamed; Al-Hendy, Ayman (2012). "Medical Treatment of Uterine Leiomyoma". Reproductive Sciences. 19 (4): 339–353. doi:10.1177/1933719111432867. ISSN 1933-7191.
- ↑ Donnez, Jacques; Dolmans, Marie-Madeleine (2016). "Uterine fibroid management: from the present to the future". Human Reproduction Update. 22 (6): 665–686. doi:10.1093/humupd/dmw023. ISSN 1355-4786.
- ↑ Murji, Ally; Whitaker, Lucy; Chow, Tiffany L; Sobel, Mara L (2017). "Selective progesterone receptor modulators (SPRMs) for uterine fibroids". Cochrane Database of Systematic Reviews. doi:10.1002/14651858.CD010770.pub2. ISSN 1465-1858.
- ↑ Arena, Saverio; Zupi, Errico (2011). "Heavy Menstrual Bleeding: Considering the Most Effective Treatment Option". Women's Health. 7 (2): 143–146. doi:10.2217/WHE.11.1. ISSN 1745-5065.
- ↑ De Leo, Vincenzo; Morgante, Giuseppe; La Marca, Antonio; Musacchio, Maria Concetta; Sorace, Massimo; Cavicchioli, Chiara; Petraglia, Felice (2002). "A Benefit-Risk Assessment of Medical Treatment for Uterine Leiomyomas". Drug Safety. 25 (11): 759–779. doi:10.2165/00002018-200225110-00002. ISSN 0114-5916.
- ↑ Sankaran, Srividhya; Manyonda, Isaac T. (2008). "Medical management of fibroids". Best Practice & Research Clinical Obstetrics & Gynaecology. 22 (4): 655–676. doi:10.1016/j.bpobgyn.2008.03.001. ISSN 1521-6934.